Harlem Strong Mental Health Coalition Study
This study, called the Harlem Strong Mental Health Coalition, is looking at how a community-wide effort can improve mental health for people in Harlem. It involves training healthcare providers to better screen for mental health issues, provide education, and connect people to social services. Community Health Workers (CHWs) will also receive ongoing support and training. The goal is to improve how mental health care is delivered and accessed. We're looking for Black and Latino adults between 18 and 65 years old who live in Harlem, especially those in low-income housing or receiving primary care in Harlem, and who show a moderate risk for depression. Success will be measured by improvements in depression (using the PHQ-9 scale) and anxiety (using the GAD-7 scale) over 6 to 12 months, and how many people are screened for mental health issues over 24 months. The current recruitment status is unclear.
- Study design
- This is an interventional study planning to enroll 700 participants. It is not specified if it is randomized or blinded.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for outcomes related to depression and anxiety for 6 to 12 months, and for screening reach for up to 24 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Harlem Strong Mental Health Coalition
At a glance
Conditions
NCT05833555
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
CUNY Graduate School of Public Health and Health Policy
New York, New Yorkstudy coordinator listed
Recruiting
Harlem Congregation for Community Improvement
New York, New Yorkstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Victoria K Ngo, PhD · PRINCIPAL_INVESTIGATOR · City University of New York
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Depression - PHQ-96-12 months
Depression symptom severity is assessed using the Patient Health Questionnaire (PHQ-9), which includes nine items on a scale ranging from "0" (Not at all) to "3" (Nearly every day). PHQ-9 scores range from 0 to 27, with higher scores indicating greater severity of depression. The scores are categorized into five levels: minimal (0-4), mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20-27).
- Anxiety - GAD-76-12 months
Anxiety symptom severity is assessed using the General Anxiety Disorder (GAD-7) scale, which consists of seven items designed to screen and evaluate anxiety symptom severity on a scale ranging from "0" (Not at all) to "3" (Nearly every day). GAD-7 scores range from 0 to 21, with higher scores indicating greater anxiety symptoms. Scores are classified into four levels: minimal (0-4), mild (5-9), moderate (10-14), and severe (15-21).
- Reach of Screening0-24 months
Number of new consumers screened for depression using the Patient Health Questionnaire (PHQ-4) relative to the total number of low-income housing residents or patients seen at the sites will be used.
- Mental Health Service Linkage0-24 months
% of successful MH linkages (connecting with MH navigator or MH referrals).